Hire Mobile App Developer for Biotech Startups
Senior, direct, no layers

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do. The recurring friction is experimental data scattered across notebooks and drives, CRO results arriving late or in unusable formats, and investor updates rebuilt from scratch every month.

A mobile app developer builds the application for the work that happens away from a desk: quick updates, timely reminders, and tasks completed on a phone. For biotech startups, that means the parts of assay development and validation that genuinely benefit from being mobile, built natively or cross-platform as the job demands.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, an app that lets the user complete the update in seconds on their phone — and syncs it to an electronic lab notebook such as Benchling — would keep the record current instead of waiting for a desk. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

The stack here is an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals. The gap is usually connection, not tools: work lands in one system, records live in another, and nobody has one view of where a case stands. This engagement connects that stack and standardises the routines around it.

The app connects to an electronic lab notebook such as Benchling through its interfaces, with a LIMS alongside where the workflow needs it. The organization's systems remain the record; the app is the mobile window into them.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

The realistic outcome is data the team can actually use: experiments findable, CRO results comparable, and updates assembled from real results instead of rebuilt each time.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is where work happens: updates and reminders move to the moment they matter, and the office record stays current without end-of-day catch-up.

Browse all hire engagements or discuss your biotech startup workflow directly.